Release Date: 27/12/18 15:07 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 247.7KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%